National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -10 of 280         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Closed


18 and over


Other


02-0484-C
NCT00160875


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Closed


20 to 75


Pharmaceutical / Industry


01023010 / TOP-003
NCT00284258

Last Modified: 12/1/1998  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 and over


Pharmaceutical / Industry


MSKCC-95051
P-UPJOHN-MSKCC-95051, NCI-V96-0913

Last Modified: 5/17/2007     First Published: 5/1/1998  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 to 75


Pharmaceutical / Industry


FRE-GERCOR-C97-3/CPTF308
FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260

Last Modified: 9/10/2008     First Published: 5/1/1999  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Completed


18 and over


NCI


CLB-89803
CAN-NCIC-CO15, E-89803, NCCTG-C89803, SWOG-C89803, NCT00003835, C89803, CO15

Last Modified: 6/1/2007     First Published: 3/1/2000  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 and over





EORTC-40986
NCT00004885

Last Modified: 6/18/2008     First Published: 4/1/2000  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 and over


NCI


NCCTG-N9841
ECOG-N9841, SWOG-N9841, NCT00005036, N9841

Last Modified: 6/12/2007     First Published: 7/1/2000  

8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Closed


18 to 75


Other


FRE-FNCLCC-ACCORD-2
FFCD-9802, EU-20014, NCT00005979

Last Modified: 2/8/2007     First Published: 8/1/2000  

9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Completed


Not specified


NCI


CLB-9864
E-C9864, NCT00006103, C9864

Last Modified: 3/1/2001     First Published: 9/1/2000  

10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Closed


18 and over


Pharmaceutical / Industry


NOVARTIS-CSMS995US05
NCT00006269

   
  Display for Print   New Search 1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov